Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[PSA-based parameters].

Jun Nakashima1

  • 1Department of Urology, Keio University School of Medicine.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|February 18, 2005
PubMed
Summary
This summary is machine-generated.

Serum prostate-specific antigen (PSA) screening for prostate cancer leads to unnecessary biopsies. New PSA isoforms and human glandular kallikrein 2 show promise in improving diagnostic accuracy and reducing invasive procedures.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Improvement in survival of patients with higher risk but not lower risk myelodysplastic syndromes over 20 years: A retrospective study from Nagasaki, Japan.

British journal of haematology·2026
Same author

Efficacy of Azacitidine Plus Venetoclax in Acute Myeloid Leukemia Transformed from Myelodysplastic Syndrome after Failure of Azacitidine Monotherapy.

Internal medicine (Tokyo, Japan)·2025
Same author

Salvage robotic-assisted radical prostatectomy in a patient with recurrence after two sessions of heavy ion radiotherapy.

Journal of surgical case reports·2024
Same author

Validation of a Supportive and Palliative Care Indicator Tool Among Patients Hospitalized Due to Heart Failure.

Journal of cardiac failure·2024
Same author

Improvement of Light Chain Proximal Tubulopathy without Crystals in IgGλ-type Monoclonal Gammopathy of Undetermined Significance Using Bortezomib and Dexamethasone.

Internal medicine (Tokyo, Japan)·2023
Same author

Prostate-specific antigen nomogram to predict advanced prostate cancer using area under the receiver operating characteristic curve boosting.

Urologic oncology·2022

Area of Science:

  • Urology
  • Oncology
  • Biochemistry

Background:

  • Serum prostate-specific antigen (PSA) is a key biomarker for prostate cancer screening and early detection.
  • Elevated PSA levels, particularly in the 4-10 ng/mL range, often necessitate prostate biopsies, leading to a high rate of unnecessary procedures.
  • Current methods for improving PSA specificity include age-specific ranges, PSA velocity, and volume-adjusted PSA.

Purpose of the Study:

  • To explore novel biomarkers for improving the specificity of prostate cancer diagnosis.
  • To investigate the clinical utility of free PSA isoforms and human glandular kallikrein 2 (hK2).
  • To reduce the number of unnecessary prostate biopsies without compromising cancer detection rates.

Main Methods:

  • Review of recent advancements in PSA isoform analysis.

Related Experiment Videos

  • Analysis of studies investigating free PSA isoforms (e.g., pPSA, BPSA).
  • Evaluation of the role of human glandular kallikrein 2 in prostate cancer diagnostics.

    • Main Results:

    • Free PSA comprises several isoforms, including pPSA and BPSA, which may offer improved diagnostic information.
    • Emerging research suggests that these new PSA isoforms and hK2 hold potential for enhancing diagnostic accuracy.
    • These novel markers could help differentiate between prostate cancer and benign conditions, thereby reducing unnecessary biopsies.

    Conclusions:

    • Further investigation into the clinical value of novel PSA isoforms and hK2 is crucial.
    • These biomarkers are anticipated to significantly reduce unnecessary prostate biopsies in the near future.
    • Improved diagnostic specificity will enhance early prostate cancer detection while minimizing patient burden.